In 2022 and 2023, the mHealthINX consortium conducted field study to evaluate the mHealthINX system’s usability, acceptance, and effectiveness in reducing stress and improving the well-being of employees (50+). This study consisted of a usability/functionality trial in Switzerland and a randomized-controlled trial in the Netherlands. In addition, qualitative data from all participating countries collected and analyzed by offering individual deep-dive and exit interviews for interested users to gain more detailed feedback on the technology use and their individual experiences with mHealthINX. Workshops with other relevant stakeholders were held to include their perspective on introducing digital stress management in organizational settings.

The project partners analyzed all data from the evaluation study and stakeholder workshops. Unfortunately, compared with a control group, no significant effect of the system’s use regarding stress reduction after 12 weeks could be shown. However, the feedback collected when interacting with the users during the study period and from deep-dive and exit interviews at the end of the trials showed that many people emphasized the new technology as possibility to support people’s health at the workplace. Some employees also reported challenges when using the technology at work and home, which will build the basis for further improvements of the different components.

The data collected, and information given on the mHealthINX system from the perspectives of employees 50+ but also from other stakeholders like healthcare providers, decision-makers, and health authorities are valuable and of great importance for further developing and adapting the mHealthINX system and implementing it in different settings in the future.